Condition
PET/CT Imaging
Total Trials
5
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
Early P 1 (1)
P 2 (2)
Trial Status
Recruiting3
Not Yet Recruiting1
Unknown1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07685197Phase 2Not Yet Recruiting
Comparative ¹⁸F-FDG and ⁶⁸Ga-MY6349 PET/CT Imaging for Assessing TROP2 ADC Therapeutic Efficacy in EGFR-TKI Resistant Advanced NSCLC
NCT07325253Phase 2Recruiting
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
NCT06911697Not ApplicableRecruitingPrimary
Study on c-Met Targeted PET/CT Imaging in NSCLC
NCT05549024Early Phase 1Recruiting
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
NCT03519659Not ApplicableUnknownPrimary
Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT
Showing all 5 trials